Literature DB >> 16494469

One-step, three-component synthesis of pyridines and 1,4-dihydropyridines with manifold medicinal utility.

Nikolai M Evdokimov1, Igor V Magedov, Artem S Kireev, Alexander Kornienko.   

Abstract

Privileged medicinal scaffolds based on the structures of 2-amino-3,5-dicyano-6-sulfanylpyridines and the corresponding 1,4-dihydropyridines have been prepared via a single-step, three-component reaction of structurally diverse aldehydes with various thiols and malononitrile. Mechanistic studies revealed that 1,4-dyhidropyridines undergo oxidation by the intermediate Knoevenagel adducts rather than by air oxygen. Although the latter process undermines the yields of pyridines, it results in the formation of substituted enaminonitriles, promising antiinflammatory agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494469     DOI: 10.1021/ol052994+

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  11 in total

1.  Multicomponent Synthesis of 2,3-Dihydrochromeno[4,3-d]pyrazolo[3,4-b]pyridine-1,6-diones: A Novel Heterocyclic Scaffold with Antibacterial Activity.

Authors:  Liliya V Frolova; Indranil Malik; Pavel Y Uglinskii; Snezna Rogelj; Alexander Kornienko; Igor V Magedov
Journal:  Tetrahedron Lett       Date:  2011-12-07       Impact factor: 2.415

Review 2.  Recent developments in utility of green multi-component reactions for the efficient synthesis of polysubstituted pyrans, thiopyrans, pyridines, and pyrazoles.

Authors:  Mohamed Hilmy Elnagdi; Moustafa Sherief Moustafa; Saleh Mohammed Al-Mousawi; Ramadan Ahmed Mekheimer; Kamal Usef Sadek
Journal:  Mol Divers       Date:  2015-04-17       Impact factor: 2.943

Review 3.  Transition metal-mediated synthesis of monocyclic aromatic heterocycles.

Authors:  Anton V Gulevich; Alexander S Dudnik; Natalia Chernyak; Vladimir Gevorgyan
Journal:  Chem Rev       Date:  2013-01-10       Impact factor: 60.622

4.  Convenient one-step synthesis of a medicinally relevant benzopyranopyridine system.

Authors:  Nikolai M Evdokimov; Artem S Kireev; Andrey A Yakovenko; Mikhail Yu Antipin; Igor V Magedov; Alexander Kornienko
Journal:  Tetrahedron Lett       Date:  2006-12-25       Impact factor: 2.415

5.  A new one-pot three-component synthesis of 2,4-diamino-5H-chromeno[2,3-b]pyridine-3-carbonitrile derivatives.

Authors:  Ahmad Shaabani; Fatemeh Hajishaabanha; Hamid Mofakham; Ali Maleki
Journal:  Mol Divers       Date:  2009-05-16       Impact factor: 2.943

6.  Multi-component synthesis of 2-amino-6-(alkyllthio)pyridine-3,5-dicarbonitriles using Zn(II) and Cd(II) metal-organic frameworks (MOFs) under solvent-free conditions.

Authors:  Muralidhara Thimmaiah; Peng Li; Sridhar Regati; Banglin Chen; John Cong-Gui Zhao
Journal:  Tetrahedron Lett       Date:  2012-09-05       Impact factor: 2.415

7.  Novel three-component synthesis and antiproliferative properties of diversely functionalized pyrrolines.

Authors:  Igor V Magedov; Giovanni Luchetti; Nikolai M Evdokimov; Madhuri Manpadi; Wim F A Steelant; Severine Van Slambrouck; Paul Tongwa; Mikhail Yu Antipin; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2008-01-11       Impact factor: 2.823

Review 8.  Non-Nucleoside Agonists of the Adenosine Receptors: An Overview.

Authors:  Diego Dal Ben; Catia Lambertucci; Michela Buccioni; Aleix Martí Navia; Gabriella Marucci; Andrea Spinaci; Rosaria Volpini
Journal:  Pharmaceuticals (Basel)       Date:  2019-10-08

Review 9.  2-Amino-3,5-dicarbonitrile-6-sulfanylpyridines: synthesis and multiple biological activity - a review.

Authors:  Nail S Akhmadiev; Vnira R Akhmetova; Askhat G Ibragimov
Journal:  RSC Adv       Date:  2021-03-23       Impact factor: 3.361

10.  Synthesis of indeno-[1,2-b]-quinoline-9,11(6H,10H)-dione and 7,7-dimethyl-10-aryl-7,8-dihydro-5H-indeno[1,2-b]quinoline-9,11(6H,10H)-dione derivatives in presence of heterogeneous Cu/zeolite-Y as a catalyst.

Authors:  Shankar D Dhengale; Chandrashekhar V Rode; Govind B Kolekar; Prashant V Anbhule
Journal:  RSC Adv       Date:  2022-01-13       Impact factor: 3.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.